Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [21] Vinorelbine, carboplatin and gemcitabine (VGC) in the treatment of untreated advanced/metastatic non-small cell lung cancer (NSCLC): A phase I study
    Piantedosi, FV
    Pontillo, V
    Brancaccio, L
    Crispino, C
    Biscione, GL
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S255 - S255
  • [22] Combination of Gemcitabine (Gem) and Carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC)
    Carrato, A
    Alberola, V
    Massuti, B
    Galan, A
    Sanchez, JJ
    Garcia-Gomez, J
    Diaz-Fernandez, N
    Meana, A
    Rodriguez-Lescure, A
    Gonzalvez, ML
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 90
  • [23] Gemcitabine (GEM) and carboplatin (CBDCA) combination as first line treatment in non-small cell lung cancer.
    Alberola, V
    Carralo, A
    Massuti, B
    Juan, O
    Sánchez, JJ
    Gómez, JG
    Fernández, ND
    Meana, A
    Rodríguez-Lescure, A
    González, ML
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S66 - S66
  • [24] Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study
    Kortsik, C
    Albrecht, P
    Elmer, A
    LUNG CANCER, 2003, 40 (01) : 85 - 90
  • [25] A randomized comparison of carboplatin/vinorelbine versus carboplatin/gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Helbekkmo, N.
    Sundtroem, S. H.
    Aaseboe, U.
    Brunsvig, P. F.
    Von Plessen, C. L.
    Bremnes, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 372S - 372S
  • [26] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    LUNG CANCER, 2002, 36 (01) : 99 - 103
  • [27] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [28] Past, present, and future of gemcitabine and carboplatin regimens in advanced non-small cell lung cancer
    Edelman, MJ
    LUNG CANCER, 2002, 38 : S37 - S43
  • [29] Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer
    Horvath, L
    Boyer, M
    Clarke, S
    Beale, P
    Beith, J
    Underhill, C
    Stockler, M
    Bishop, J
    LUNG CANCER, 2001, 32 (02) : 173 - 178
  • [30] Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Thongprasert, Sumitra
    Govindan, Ramaswamy
    Krzakowski, Maciej
    Szczesna, Aleksandra
    Strausz, Janos
    Makhson, Anatoly
    Tye, Lesley
    Zhang, Ke
    Chao, Richard C.
    Scagliotti, Giorgio V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
12345